February 17, 2022
It’s with great pride that I share a sampling of the many extraordinary accomplishments of last year in our first Lupus Research Update of 2022. The Lupus Research Alliance (LRA) made important gains on many fronts—thanks to tremendous friends like you.
I hope you share my pride because your support continues to be the catalyst behind every LRA accomplishment.
| To fully appreciate the key role you play, I invite you to read about the myriad of inquiries we are currently funding … the newly approved therapies for lupus nephritis—which the LRA helped advance through pioneering investigations over the past two decades … a clinical trial with BMS using iberdomide, which appears to reduce the severity of lupus … and much more! | Remember that 100% of yourgift will go towardlupus research.*Please give generously. |
With your support, the LRA is pushing the boundaries of lupus research, while bringing us closer to treatments that are much more targeted and refined, with far fewer side effects … and ultimately a cure.
We’re working hard — but we must do more. This is why I am calling on you to help the LRA keep the cutting-edge of scientific research and medical treatment moving forward.
Sincerely,
Kenneth M. FarberPresident & CEO, LRA
* 100% of all donations goes to support lupus research programs because the Lupus Research Alliance Board of Directors funds all administrative and fundraising costs.
